2018
DOI: 10.1107/s2059798318010380
|View full text |Cite
|
Sign up to set email alerts
|

Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330

Abstract: Lithium, which is still the gold standard in the treatment of bipolar disorder, has been proposed to inhibit inositol monophosphatase (IMPase) and is hypothesized to exert its therapeutic effects by attenuating phosphatidylinositol (PI) cell signalling. Drug‐discovery efforts have focused on small‐molecule lithium mimetics that would specifically inhibit IMPase without exhibiting the undesired side effects of lithium. L‐690,330 is a potent bisphosphonate substrate‐based inhibitor developed by Merck Sharp & Doh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 6 publications
(14 citation statements)
references
References 27 publications
0
13
0
1
Order By: Relevance
“…Cys125 has no surface accessibility whether oxidised or reduced. A partial Cys25-Cys125 disulphide is also observed in 6GJ0 (Kraft et al, 2018).…”
Section: Human Impase Structure With Ebselen On Cysteine 141mentioning
confidence: 87%
See 4 more Smart Citations
“…Cys125 has no surface accessibility whether oxidised or reduced. A partial Cys25-Cys125 disulphide is also observed in 6GJ0 (Kraft et al, 2018).…”
Section: Human Impase Structure With Ebselen On Cysteine 141mentioning
confidence: 87%
“…The IMPase construct was described by Kraft et al 2018, with Rossetta2(DE3) E. coli used for IMPase production. A starter culture (10 ml) of transformed E. coli was grown overnight and used to inoculate 1L of LB medium containing 2.5 mM betaine, 660 mM sorbitol, 35 mg/ml chloramphenicol and 50 mg/ml ampicillin.…”
Section: Macromolecule Productionmentioning
confidence: 99%
See 3 more Smart Citations